Atlas Trials

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Clinical trial NCT07218146 · RECRUITING

Trial details

NCT number
NCT07218146
Sponsor
Zai Lab (Shanghai) Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Small-cell Lung Cancer
Start date
2025-11-30
Primary completion
2028-06-30
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.